Semper Paratus Acquisition Corporation Announces Anticipated Listing Of Tevogen Bio Holdings Inc. On Nasdaq
Portfolio Pulse from Benzinga Newsdesk
Semper Paratus Acquisition Corporation (NASDAQ:LGST, LGSTW) has filed a Prospectus Supplement to its definitive proxy statement/prospectus for an extraordinary general meeting to vote on a Business Combination with Tevogen Bio Inc. The merger will result in Semper Paratus de-registering from the Cayman Islands, redomesticating to Delaware, and renaming to Tevogen Bio Holdings Inc. The combined entity plans to list its common stock and public warrants on Nasdaq instead of NYSE American.
January 24, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Semper Paratus Acquisition Corporation is preparing for a Business Combination with Tevogen Bio, which will lead to a new listing on Nasdaq as Tevogen Bio Holdings Inc. Shareholders will vote on this transaction on January 29, 2024.
The announcement of the Business Combination and the planned Nasdaq listing is likely to be viewed positively by investors, as it signifies growth and expansion. The change from NYSE American to Nasdaq could also be perceived as a strategic move to attract a broader investor base. The upcoming shareholder vote adds a level of certainty to the proceedings, which can be reassuring to investors.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100